This episode of Rethinking Diabetes breaks down the newest evidence on once-weekly basal insulin, including data from five major trials and the surprising safety concerns that emerged. We explore real-world implications, from hypoglycemia risk to CGM-guided titration, and what it all means for patient selection, adherence, and the future of diabetes care.

We’ve long underestimated the pancreas — but new research reveals it's more than a digestive workhorse. From real-time hormone tracking and microRNA surprises to oxytocin’s metabolic role and age-defying molecules like taurine, this episode uncovers how the pancreas choreographs a complex interplay of aging, immunity, and energy regulation. Get ready for a deep dive into the science that's reshaping how we understand — and treat — metabolic disease.

This week on Rethinking Diabetes, we explore a major discovery linking low PAPP-A levels in early pregnancy to a 75% higher risk of gestational diabetes — and what that means for early intervention. From metabolic “vicious cycles” to cutting-edge assays and the post-COVID rise in complications, this episode connects the latest findings across reproductive health, immunology, and metabolic science to spotlight a more personalized future for diabetes care.

What’s new in type 2 diabetes research? In this episode, we explore the latest studies on pathogenesis, early diagnosis, personalized treatment strategies, and connections with conditions like MASLD and neurodegenerative disorders. We also discuss youth-onset diabetes, intensive therapy approaches, digital interventions, and emerging pharmacological targets. A weekly roundup to stay updated on the science that matters.

In this episode, we explore how recent research is reshaping our understanding of diabetes—not just as a blood sugar disorder, but as a complex condition involving genetics, immune response, and cellular aging. We cover groundbreaking findings from the Type 1 Diabetes Genetics Consortium, new insights into maternal diabetes and fetal development, the role of vitamin D, emerging vascular biomarkers, financial toxicity, health disparities, and the evolving concept of insulin resistance in type 1 diabetes. Tune in for a fast-paced, evidence-based recap designed for healthcare professionals and curious minds alike.